<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK525917" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK525917/" /><meta name="ncbi_pagename" content="KCNT1-Related Epilepsy - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>KCNT1-Related Epilepsy - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="KCNT1-Related Epilepsy" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/09/20" /><meta name="citation_author" content="Tracy Gertler" /><meta name="citation_author" content="David Bearden" /><meta name="citation_author" content="Arin Bhattacharjee" /><meta name="citation_author" content="Gemma Carvill" /><meta name="citation_pmid" content="30234941" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK525917/" /><meta name="citation_keywords" content="Potassium channel subfamily T member 1" /><meta name="citation_keywords" content="KCNT1" /><meta name="citation_keywords" content="KCNT1-Related Epilepsy" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="KCNT1-Related Epilepsy" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Tracy Gertler" /><meta name="DC.Contributor" content="David Bearden" /><meta name="DC.Contributor" content="Arin Bhattacharjee" /><meta name="DC.Contributor" content="Gemma Carvill" /><meta name="DC.Date" content="2018/09/20" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK525917/" /><meta name="description" content="KCNT1-related epilepsy is most often associated with two phenotypes: epilepsy of infancy with migrating focal seizures (EIMFS) and autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)." /><meta name="og:title" content="KCNT1-Related Epilepsy" /><meta name="og:type" content="book" /><meta name="og:description" content="KCNT1-related epilepsy is most often associated with two phenotypes: epilepsy of infancy with migrating focal seizures (EIMFS) and autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK525917/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/kcnt1-epilepsy/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK525917/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C22F0E04173210000000000450016.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK525917_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK525917_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/kcnq3-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/kmt2b-dystonia/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK525917_"><span class="title" itemprop="name"><i>KCNT1</i>-Related Epilepsy</span></h1><p class="contrib-group"><span itemprop="author">Tracy Gertler</span>, MD, PhD, <span itemprop="author">David Bearden</span>, MD, MSCE, <span itemprop="author">Arin Bhattacharjee</span>, PhD, and <span itemprop="author">Gemma Carvill</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK525917_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK525917_ai__"><div class="contrib half_rhythm"><span itemprop="author">Tracy Gertler</span>, MD, PhD<div class="affiliation small">Department of Pediatrics<br />Ann and Robert H Lurie Children's Hospital of Chicago<br />Chicago, Illinois</div></div><div class="contrib half_rhythm"><span itemprop="author">David Bearden</span>, MD, MSCE<div class="affiliation small">Department of Neurology<br />Division of Child Neurology<br />University of Rochester School of Medicine<br />Rochester, New York</div></div><div class="contrib half_rhythm"><span itemprop="author">Arin Bhattacharjee</span>, PhD<div class="affiliation small">Department of Pharmacology<br />University of Buffalo<br />Buffalo, New York</div></div><div class="contrib half_rhythm"><span itemprop="author">Gemma Carvill</span>, PhD<div class="affiliation small">Department of Neurology<br />Feinberg School of Medicine<br />Northwestern University<br />Chicago, Illinois</div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">September 20, 2018</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="kcnt1-epilepsy.Summary" itemprop="description"><h2 id="_kcnt1-epilepsy_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>KCNT1-</i>related epilepsy is most often associated with two phenotypes: epilepsy of infancy with migrating focal seizures (EIMFS) and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> nocturnal frontal lobe epilepsy (ADNFLE).</p><ul><li class="half_rhythm"><div>EIMFS is characterized by seizures, typically focal and asynchronous, beginning in the first six months of life with associated developmental plateau or regression. Autonomic manifestations (e.g., perioral cyanosis, flushing, apnea) are common. Seizures are intractable to multiple anticonvulsants and progress to become nearly continuous by age six to nine months.</div></li><li class="half_rhythm"><div>ADNFLE is characterized by clusters of nocturnal motor seizures that vary from simple arousals to hyperkinetic events with tonic or dystonic features. Individuals with <i>KCNT1</i>-related ADNFLE are more likely to develop seizures at a younger age, have cognitive comorbidity, and display psychiatric and behavioral problems than individuals with ADNFLE due to other causes.</div></li></ul><p>Less common seizure phenotypes in individuals with <i>KCNT1-</i>related epilepsy include West syndrome, Ohtahara syndrome, early myoclonic encephalopathy, leukodystrophy and/or leukoencephalopathy, focal epilepsy, and multifocal epilepsy. Additional neurologic features include hypotonia, microcephaly developing by age 12 months, strabismus, profound developmental delay, and additional movement disorders. Other systemic manifestations including pulmonary hemorrhage caused by prominent systemic-to-pulmonary collateral arteries or cardiac arrhythmia have been reported.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>KCNT1</i>-related epilepsy is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with intractable epilepsy and identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KCNT1</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations. KCNT1</i>-related epilepsy is often refractory to conventional anticonvulsants; stiripentol, benzodiazepines, levetiracetam, and the ketogenic diet have all been well tolerated with limited success; quinidine has been used as an off-label anticonvulsant with success in some individuals; in rare cases of pulmonary hemorrhage due to systemic pulmonary collaterals, embolization has been recommended; developmental support is appropriate.</p><p><i>Surveillance.</i> EEG at intervals determined by seizure frequency and progression, for evaluation of new involuntary movements or unexplained, paroxysmal changes in vital signs, or following adjustments to an anticonvulsant regimen; monitoring of development.</p><p><i>Agents/circumstances to avoid:</i> For individuals with ADNFLE, activities in which a sudden loss of consciousness could lead to injury or death should be avoided (e.g., bathing, swimming, driving, or working/playing at heights).</p><p><i>Pregnancy management:</i> For women with ADNFLE, a discussion of the risks and benefits of using a given antiepileptic drug during pregnancy should ideally take place before conception. Transitioning to a lower-risk medication prior to pregnancy may be possible<i>.</i></p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>KCNT1</i>-related epilepsy is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. The majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) resulting from a <i>de novo KCNT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant varies by <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. All individuals diagnosed with <i>KCNT1</i>-related epilepsy of infancy with migrating focal seizures (EIMFS) have the disorder as the result of a <i>de novo</i> pathogenic variant or an inherited variant from an unaffected parent with somatic and/or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. Some individuals diagnosed with <i>KCNT1</i>-related autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) have an affected parent. Each child of an individual with <i>KCNT1</i>-related epilepsy has a 50% chance of inheriting the pathogenic variant, and intrafamilial clinical variability and reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> have been reported. Prenatal diagnosis for pregnancies at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible if the pathogenic variant in the family is known.</p></div></div><div id="kcnt1-epilepsy.Diagnosis"><h2 id="_kcnt1-epilepsy_Diagnosis_">Diagnosis</h2><p>No formal diagnostic criteria for <i>KCNT1</i>-related epilepsy have been published to date.</p><p><i>KCNT1</i>-related epilepsy is most often associated with two phenotypes: epilepsy of infancy with migrating focal seizures (EIMFS) and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> nocturnal frontal lobe epilepsy (ADNFLE). Less often, <i>KCNT1</i> pathogenic variants are associated with epilepsy with variable presentation.</p><div id="kcnt1-epilepsy.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>KCNT1</i>-related epilepsy of infancy with migrating focal seizures (EIMFS) <b>should be suspected</b> in individuals with the following history and findings:</p><ul><li class="half_rhythm"><div>Normal prenatal course and birth without history, clinical features, or imaging suggestive of traumatic, anoxic, vascular, or infectious injury</div></li><li class="half_rhythm"><div>Sporadic, asynchronous focal seizures arising independently from either hemisphere with patterns of intracortical "migration" occurring by age six months, with subsequent escalation of seizure frequency</div></li><li class="half_rhythm"><div>Developmental plateau or regression following the onset of seizures</div></li><li class="half_rhythm"><div>Intractability to anticonvulsant medication</div></li></ul><p><i>KCNT1</i>-related <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> nocturnal frontal lobe epilepsy (ADNFLE) <b>should be suspected</b> in individuals with the following history and findings:</p><ul><li class="half_rhythm"><div>Frequent brief, nocturnal seizures</div></li><li class="half_rhythm"><div>Mild to moderate intellectual disability</div></li><li class="half_rhythm"><div>Psychiatric disease (e.g., depression, anxiety, suicidality, attention deficit hyperactivity disorder)</div></li><li class="half_rhythm"><div>Family history of ADNFLE or EIMFS</div></li></ul><p><i>KCNT1-</i>related epilepsy has been less frequently identified in individuals with the following phenotypes:</p><ul><li class="half_rhythm"><div>West syndrome</div></li><li class="half_rhythm"><div>Ohtahara syndrome (early-infantile epileptic encephalopathy)</div></li><li class="half_rhythm"><div>Early myoclonic encephalopathy</div></li><li class="half_rhythm"><div>Leukodystrophy/leukoencephalopathy</div></li><li class="half_rhythm"><div>Focal epilepsy</div></li><li class="half_rhythm"><div>Multifocal epilepsy</div></li></ul></div><div id="kcnt1-epilepsy.Establishing_the_Diagnosi"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>KCNT1</i>-related epilepsy <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with intractable epilepsy and identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KCNT1</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK525917/table/kcnt1-epilepsy.T.molecular_genetic_testi/?report=objectonly" target="object" rid-figpopup="figkcnt1epilepsyTmoleculargenetictesti" rid-ob="figobkcnt1epilepsyTmoleculargenetictesti">Table 1</a>).</p><p>Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>KCNT1</i>-related epilepsy is indistinguishable from many other inherited disorders with epilepsy, recommended <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches include use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> or <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p>Note: (1) Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>KCNT1</i>) is rarely useful and typically NOT recommended. (2) <i>KCNT1</i>-related epilepsy is postulated to occur through a <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> mechanism. Large intragenic deletions and <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> have not been reported; testing for intragenic deletions or duplication is not indicated.</p><p><b>A seizure</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>KCNT1</i> and other genes of interest (see <a href="#kcnt1-epilepsy.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is another good option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="kcnt1-epilepsy.T.molecular_genetic_testi" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>KCNT1</i>-Related Epilepsy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK525917/table/kcnt1-epilepsy.T.molecular_genetic_testi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kcnt1-epilepsy.T.molecular_genetic_testi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kcnt1-epilepsy.T.molecular_genetic_testi_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_kcnt1-epilepsy.T.molecular_genetic_testi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_kcnt1-epilepsy.T.molecular_genetic_testi_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_kcnt1-epilepsy.T.molecular_genetic_testi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNT1</i></td><td headers="hd_h_kcnt1-epilepsy.T.molecular_genetic_testi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_kcnt1-epilepsy.T.molecular_genetic_testi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.molecular_genetic_testi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_kcnt1-epilepsy.T.molecular_genetic_testi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>4,&#x000a0;6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="kcnt1-epilepsy.TF.1.1"><p class="no_margin">See <a href="/books/NBK525917/#kcnt1-epilepsy.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="kcnt1-epilepsy.TF.1.2"><p class="no_margin">See <a href="#kcnt1-epilepsy.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="kcnt1-epilepsy.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="kcnt1-epilepsy.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#kcnt1-epilepsy.REF.lim.2016.217">Lim et al [2016]</a></p></div></dd><dt>5. </dt><dd><div id="kcnt1-epilepsy.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="kcnt1-epilepsy.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#kcnt1-epilepsy.REF.mctague.2018.e55">McTague et al [2018]</a></p></div></dd></dl></div></div></div></div></div><div id="kcnt1-epilepsy.Clinical_Characteristics"><h2 id="_kcnt1-epilepsy_Clinical_Characteristics_">Clinical Characteristics</h2><div id="kcnt1-epilepsy.Clinical_Description"><h3>Clinical Description</h3><p><i>KCNT1-</i>related epilepsy encompasses a range of epilepsy syndromes. The most common phenotypes reported in individuals with <i>KCNT1</i>-related epilepsy are epilepsy of infancy with migrating focal seizures (EIMFS) and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> nocturnal frontal lobe epilepsy (ADNFLE).</p><div id="kcnt1-epilepsy.Epilepsy_Phenotype"><h4>Epilepsy Phenotype</h4><p><b>EIMFS</b> is an early infantile epileptic encephalopathy characterized by seizures beginning in the first six months of life with associated developmental plateau or regression. The seizures are primarily focal motor, variably with secondary generalization, but also include tonic, clonic, tonic-clonic, myoclonic, and epileptic spasms [<a class="bk_pop" href="#kcnt1-epilepsy.REF.mctague.2013.1578">McTague et al 2013</a>]. Autonomic manifestations (e.g., perioral cyanosis, flushing, apnea) are common. Seizures progress to become nearly continuous by age six to nine months. Seizures are intractable to multiple anticonvulsants. Rarely, status epilepticus at onset has been described [<a class="bk_pop" href="#kcnt1-epilepsy.REF.zamponi.2008.291">Zamponi et al 2008</a>]. The characteristic feature on EEG is focal ictal discharges that migrate across contiguous cortical regions and arise independently at multiple foci. An increase in amplitude and frontal predominance over time with post-ictal and interictal suppression has been noted [<a class="bk_pop" href="#kcnt1-epilepsy.REF.mctague.2018.e55">McTague et al 2018</a>].</p><p>Additional neurologic features reported in individuals with <i>KCNT1</i>-related EIMFS include hypotonia (axial&#x0003e;appendicular), decreased head growth with microcephaly developing by age 12 months, strabismus, and profound developmental delay with rare ability to ambulate or verbalize. Additional reported movement disorders include choreoathetosis, dyskinesias, and focal and generalized dystonia.</p><p>Prognosis for individuals with <i>KCNT1</i>-related EIMFS is currently unknown.</p><p><b>ADNFLE</b> is characterized by clusters of nocturnal motor seizures that vary from simple arousals to hyperkinetic events with tonic or dystonic features (see <a href="/books/n/gene/adnfle/">Autosomal Dominant Nocturnal Frontal Lobe Epilepsy</a>). Individuals with <i>KCNT1</i>-related ADNFLE are more likely to develop seizures before adolescence, have cognitive comorbidity, and display psychiatric and behavioral problems than are individuals with ADNFLE due to other causes.</p><p><b>Less common epilepsy phenotypes</b> in individuals with a <i>KCNT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include:</p><ul><li class="half_rhythm"><div>West syndrome</div></li><li class="half_rhythm"><div>Ohtahara syndrome (early infantile epileptic encephalopathy)</div></li><li class="half_rhythm"><div>Early myoclonic encephalopathy</div></li><li class="half_rhythm"><div>Leukodystrophy/leukoencephalopathy</div></li><li class="half_rhythm"><div>Focal or multifocal epilepsy</div></li></ul><p><b>Brain MRI and/or CT examination</b> is often normal prior to seizure onset, though recent studies have noted variable delayed myelination, hippocampal volume loss, and cerebellar atrophy [<a class="bk_pop" href="#kcnt1-epilepsy.REF.mctague.2018.e55">McTague et al 2018</a>]. Temporal lobe pathology as a cause versus consequence has been noted in two individuals with <i>KCNT1</i>-related temporal lobe epilepsy [<a class="bk_pop" href="#kcnt1-epilepsy.REF.hansen.2017.181">Hansen et al 2017</a>].</p><p><b>Other.</b> Prenatal history, birth, and neonatal history prior to seizure onset are normal, with no notable <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features.</p></div><div id="kcnt1-epilepsy.Pulmonary_Hemorrhage"><h4>Pulmonary Hemorrhage</h4><p>Three individuals with <i>KCNT1</i>-related EIMFS were reported to have prominent systemic-to-pulmonary collateral artery formation and subsequent pulmonary hemorrhage that developed between age four and 19 months [<a class="bk_pop" href="#kcnt1-epilepsy.REF.kawasaki.2017.270">Kawasaki et al 2017</a>]. Evaluation for pulmonary hemorrhage should be considered if an individual develops acute respiratory failure, heart failure, or hemoptysis.</p></div><div id="kcnt1-epilepsy.Cardiac_Arrhythmia"><h4>Cardiac Arrhythmia</h4><p>Brugada syndrome was reported in one individual with a <i>de novo KCNT1</i> variant [<a class="bk_pop" href="#kcnt1-epilepsy.REF.juang.2014.6733">Juang et al 2014</a>]. An individual with confirmed <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <i>KCNT1-</i>related epilepsy and an unspecified cardiac arrhythmia was reported by <a class="bk_pop" href="#kcnt1-epilepsy.REF.m_ller.2015.e114">M&#x000f8;ller et al [2015]</a>.</p></div></div><div id="kcnt1-epilepsy.GenotypePhenotype_Correla"><h3>Genotype-Phenotype Correlations</h3><p>There is some evidence for a <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation. However, disparate phenotypes (e.g., ADNFLE, EIMFS) have been identified in family members with the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>EIMFS.</b> The majority of pathogenic variants associated with EIMFS occur in either the S5 transmembrane <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> or the regulator of potassium conductance domains within the C-terminus.</p><p><b>ADNFLE</b>-related pathogenic variants are concentrated in the NAD+ binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> or more distal C-terminus.</p><p>Specific correlations between genetic variant and seizure burden, developmental impairment, or medication responsiveness have not yet been elucidated.</p></div><div id="kcnt1-epilepsy.Penetrance"><h3>Penetrance</h3><p>Penetrance is reported to be 100% for <i>KCNT1</i>-related EIMFS [<a class="bk_pop" href="#kcnt1-epilepsy.REF.barcia.2012.1255">Barcia et al 2012</a>, <a class="bk_pop" href="#kcnt1-epilepsy.REF.heron.2012.1188">Heron et al 2012</a>] but is reported as reduced in <i>KCNT1</i>-related epilepsy with other seizure phenotypes [<a class="bk_pop" href="#kcnt1-epilepsy.REF.m_ller.2015.e114">M&#x000f8;ller et al 2015</a>].</p></div><div id="kcnt1-epilepsy.Nomenclature"><h3>Nomenclature</h3><p>In the initial description of EIMFS, <a class="bk_pop" href="#kcnt1-epilepsy.REF.coppola.1995.1017">Coppola et al [1995]</a> described his cohort of globally arrested infants with frequent focal, "migrating" seizures that were medically intractable as malignant migrating partial seizures of infancy (MMPSI); it has also been variably referred to as migrating partial epilepsy of infancy (MPEI). In 2010, the International League Against Epilepsy reclassified this epilepsy syndrome as EIMFS [<a class="bk_pop" href="#kcnt1-epilepsy.REF.berg.2010.676">Berg et al 2010</a>].</p></div><div id="kcnt1-epilepsy.Prevalence"><h3>Prevalence</h3><p>The prevalence of <i>KCNT1</i>-related epilepsy is unknown. To date, 88 probands with <i>KCNT1-</i>related epilepsy have been reported in the literature.</p></div></div><div id="kcnt1-epilepsy.Genetically_Related_Allel"><h2 id="_kcnt1-epilepsy_Genetically_Related_Allel_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>KCNT1</i>.</p></div><div id="kcnt1-epilepsy.Differential_Diagnosis"><h2 id="_kcnt1-epilepsy_Differential_Diagnosis_">Differential Diagnosis</h2><p>Phenotypic and EEG features associated with <i>KCNT1</i> pathogenic variants are not sufficient to diagnose <i>KCNT1</i>-related epilepsy. All genes known to be associated with early-infantile epileptic encephalopathy (&#x0003e;30 have been identified; see <a href="http://omim.org/phenotypicSeries/PS308350" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM Phenotypic Series</a>) should be included in the differential diagnosis of <i>KCNT1</i>-related epilepsy including other genes less commonly associated with epilepsy of infancy with migrating focal seizures (<a href="/books/n/gene/gefs/"><i>SCN1A</i></a>, <i>SCN2A</i>, <a href="/books/n/gene/slc12a5-e/"><i>SLC12A5</i></a>, <i>SLC25A22</i>, <i>TBC1D4</i>, <i>PLCB1</i>) and <a href="/books/n/gene/adnfle/">autosomal dominant nocturnal frontal lobe epilepsy</a> (<i>CHRNA4</i>, <i>CHRNB2</i>, <a href="/books/n/gene/depdc5-epilepsy/"><i>DEPDC5</i></a>, <i>CRH</i>).</p><p>Note: At seizure onset, it is most important to distinguish <i>KCNT1</i>-related epilepsy from potentially treatable causes of early infantile-onset epileptic encephalopathy, such as neurometabolic disorders, CNS infection, structural brain lesions, and other syndromes (see <a class="figpopup" href="/books/NBK525917/table/kcnt1-epilepsy.T.treatable_disorders_ass/?report=objectonly" target="object" rid-figpopup="figkcnt1epilepsyTtreatabledisordersass" rid-ob="figobkcnt1epilepsyTtreatabledisordersass">Table 2</a>).</p><div id="kcnt1-epilepsy.T.treatable_disorders_ass" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Treatable Disorders Associated with Early Infantile-Onset Epileptic Encephalopathy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK525917/table/kcnt1-epilepsy.T.treatable_disorders_ass/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kcnt1-epilepsy.T.treatable_disorders_ass_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_1" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Conditions</th><th id="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical Findings</th><th id="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th></tr></thead><tbody><tr><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_1" rowspan="7" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neuro-</b><br /><b>metabolic</b><br /><b>disorders</b></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pds/">Pyridoxine-dependent epilepsy</a></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALDH7A1</i></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>&#x02191; plasma &#x00026; urine alpha-aminoadipic semialdehyde</div></li><li class="half_rhythm"><div>&#x02191; plasma &#x00026; CSF pipecolic acid</div></li></ul></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seizures/encephalopathy responsive to pyridoxine</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Pyridoxamine 5'-phosphate oxidase deficiency (OMIM <a href="https://omim.org/entry/610090" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">610090</a>)</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PNPO</i></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Lactic acidemia</div></li><li class="half_rhythm"><div>Hypoglycemia</div></li></ul></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seizures/encephalopathy responsive to pyridoxal 5-prime phosphate</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/biotin/">Biotinidase deficiency</a></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BTD</i></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Deficient biotinidase enzyme activity in serum or plasma</div></li><li class="half_rhythm"><div>Ketolactic acidosis, organic aciduria, hyperammonemia</div></li><li class="half_rhythm"><div>Skin rash, alopecia, recurrent viral or fungal infections</div></li></ul></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lifelong biotin supplementation</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/glut1/">Glucose transporter 1 deficiency syndrome</a></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC2A1</i></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>&#x02193; CSF glucose concentration</div></li><li class="half_rhythm"><div>Absence seizures beginning age &#x0003c;3</div></li></ul></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ketogenic diet</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/creatine/">Creatine deficiency syndromes</a></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GAMT</i><br /><i>GATM</i><br /><i>SCL6A8</i></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR<br />XL</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cerebral creatine deficiency on brain MR spectroscopy</div></li><li class="half_rhythm"><div>Suggestive ratio of guanidinoacetate, creatine, &#x00026;/or creatinine in plasma &#x00026; urine</div></li></ul></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Creatine monohydrate supplementation</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Holocarboxylase synthetase deficiency (OMIM <a href="https://omim.org/entry/253270" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">253270</a>)</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HLCS</i></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Ketolactic acidosis, organic aciduria, hyperammonemia</div></li><li class="half_rhythm"><div>Skin rash, alopecia</div></li></ul></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Responsive to biotin</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Serine biosynthesis disorders (OMIM <a href="https://omim.org/entry/601815" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">601815</a>, <a href="https://omim.org/entry/610992" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">610992</a>, <a href="https://omim.org/entry/614023" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614023</a>)</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PHGDG</i><br /><i>PSAT1</i><br /><i>PSPH</i></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Congenital or acquired microcephaly, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataracts</div></li><li class="half_rhythm"><div>&#x02193; plasma &#x00026; CSF serine</div></li></ul></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">L-serine &#x00026; glycine supplementation can reduce seizures, improve psychomotor symptoms, &#x00026; prevent progression depending on subtype</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Infection of the CNS</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">n/a</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MRI, blood culture &#x00026;/or lumbar puncture suggestive of infection</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Antibiotic, antiviral, or antifungal therapy</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Structural brain lesions</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">n/a</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(Multi)focal lesions on brain MRI</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/tuberous-sclerosis/">Tuberous sclerosis complex</a></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TSC1</i><br /><i>TCS2</i></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>MRI brain lesions (subependymal nodules, subependymal giant cell astrocytomas, tubers, focal cortical dysplasias)</div></li><li class="half_rhythm"><div>Cardiac rhabdomyoma, skin lesions, retinal lesions, renal lesions</div></li></ul></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consideration of mTOR inhibitor for astrocytoma, additional seizure reduction</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>ARX</i>-associated encephalopathy (OMIM <a href="https://omim.org/entry/308350" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">308350</a>)</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ARX</i></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Enlarged ventricles &#x00026; T<sub>2</sub>-weighted signals in basal ganglia on brain MRI</td><td headers="hd_h_kcnt1-epilepsy.T.treatable_disorders_ass_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd></dl></div></div></div></div><div id="kcnt1-epilepsy.Management"><h2 id="_kcnt1-epilepsy_Management_">Management</h2><div id="kcnt1-epilepsy.Evaluations_Following_Ini"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>KCNT1</i>-related epilepsy, the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Prolonged video EEG monitoring to evaluate electroclinical and electrographic seizure burden in consultation with a pediatric epileptologist</div></li><li class="half_rhythm"><div>Evaluation by a movement disorder specialist if dictated by clinical presentation</div></li><li class="half_rhythm"><div>Consideration of echocardiogram to evaluate for pulmonary collaterals</div></li><li class="half_rhythm"><div>Electrocardiogram (EKG) to evaluate for cardiac rhythm abnormalities</div></li><li class="half_rhythm"><div>Cognitive and behavioral assessment</div></li><li class="half_rhythm"><div>Physical, occupational, and speech therapy evaluation</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="kcnt1-epilepsy.Treatment_of_Manifestatio"><h3>Treatment of Manifestations</h3><p><b>Seizures.</b>
<i>KCNT1</i>-related epilepsy is often refractory to conventional anticonvulsants.</p><ul><li class="half_rhythm"><div><b>Stiripentol</b> in combination with a <b>benzodiazepine</b> (commonly clonazepam or clobazam), levetiracetam, and the <b>ketogenic diet</b> have all been well tolerated with limited success [<a class="bk_pop" href="#kcnt1-epilepsy.REF.hmaimess.2006.55">Hmaimess et al 2006</a>, <a class="bk_pop" href="#kcnt1-epilepsy.REF.caraballo.2008.497">Caraballo et al 2008</a>, <a class="bk_pop" href="#kcnt1-epilepsy.REF.cilio.2009.66">Cilio et al 2009</a>, <a class="bk_pop" href="#kcnt1-epilepsy.REF.mctague.2018.e55">McTague et al 2018</a>].</div></li><li class="half_rhythm"><div>Vagal nerve stimulator (VNS) has not been shown to be effective [<a class="bk_pop" href="#kcnt1-epilepsy.REF.zamponi.2008.291">Zamponi et al 2008</a>].</div></li><li class="half_rhythm"><div><b>Quinidine.</b> Seizure control and developmental progression with off-label use of quinidine was reported in an individual with <i>KCNT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> p.Arg428Gln [<a class="bk_pop" href="#kcnt1-epilepsy.REF.bearden.2014.457">Bearden et al 2014</a>], prompting subsequent treatment trials in individuals with the same and other pathogenic variants with negative results [<a class="bk_pop" href="#kcnt1-epilepsy.REF.mullen.2018.e67">Mullen et al 2018</a>] and pro-arrhythmic cardiotoxicity. Potential explanations for this variable responsiveness include genetic/epigenetic modifiers of <i>KCNT1</i> as well as polymorphisms in P-glycoprotein transporters, which actively shuttle quinidine across the blood-brain barrier [<a class="bk_pop" href="#kcnt1-epilepsy.REF.liu.2015.1795">Liu et al 2015</a>]. The limited efficacy may also be narrowed by epilepsy type, as a small, randomized, placebo-controlled, crossover clinical trial of <i>KCNT1</i>-related ADNFLE showed no efficacy [<a class="bk_pop" href="#kcnt1-epilepsy.REF.mullen.2018.e67">Mullen et al 2018</a>]. It has also been suggested that quinidine administered after age four years may be less effective [<a class="bk_pop" href="#kcnt1-epilepsy.REF.abdelnour.2018.1">Abdelnour et al 2018</a>]. In addition, given the increased risk for arrhythmia associated with quinidine treatment, some individuals are not able to achieve adequate serum levels due to the development of life-threating cardiac rhythm abnormalities, thus limiting its utility.</div></li><li class="half_rhythm"><div><b>Caregivers.</b> For information on non-medical interventions and coping strategies for parents or caregivers of children diagnosed with epilepsy, see <a href="http://www.epilepsy.com/sites/core/files/atoms/files/English_Toolkit_updated%202014.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy &#x00026; My Child Toolkit</a>.</div></li></ul><p><b>Pulmonary collaterals and pulmonary hemorrhage.</b> Embolization of systemic pulmonary collateral arteries has been used with limited success [<a class="bk_pop" href="#kcnt1-epilepsy.REF.kawasaki.2017.270">Kawasaki et al 2017</a>].</p><div id="kcnt1-epilepsy.Developmental_Delay__Inte"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the US, an IEP based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</div></li><li class="half_rhythm"><div>Discussion about transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="kcnt1-epilepsy.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility.</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy (typically from an occupational or speech therapist) is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties.</p></div><div id="kcnt1-epilepsy.SocialBehavioral_Concerns"><h4>Social/Behavioral Concerns</h4><p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is targeted to the individual child's behavioral, social, and adaptive strengths and weaknesses and is typically performed one on one with a board-certified behavior analyst.</p><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavior management strategies or providing prescription medications (e.g., to treat attention deficit hyperactivity disorder) when necessary.</p><p>Concerns about serious aggressive or destructive behavior can be addressed by a pediatric psychiatrist.</p></div></div><div id="kcnt1-epilepsy.Surveillance"><h3>Surveillance</h3><p>EEG is recommended at intervals determined by seizure frequency and progression, for evaluation of new involuntary movements or unexplained, paroxysmal changes in vital signs, or following adjustments to an anticonvulsant regimen.</p><p>Developmental evaluation and initiation of therapies is recommended at time of diagnosis if not already begun.</p><p>Following initial EKG and echocardiogram, there is no indication to repeat cardiac monitoring or cardiopulmonary imaging unless clinically indicated or following initiation of quinidine therapy.</p></div><div id="kcnt1-epilepsy.AgentsCircumstances_to_Av"><h3>Agents/Circumstances to Avoid</h3><p>No anticonvulsants have been noted to exacerbate <i>KCNT1-</i>related epilepsy.</p><p>For individuals with ADNFLE, activities in which a sudden loss of consciousness could lead to injury or death should be avoided (e.g., bathing, swimming, driving, or working/playing at heights).</p></div><div id="kcnt1-epilepsy.Evaluation_of_Relatives_a"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the genetic status of apparently asymptomatic at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the <i>KCNT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family. Family members who are found to have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>KCNT1</i> pathogenic variant are at risk for seizures and cardiac arrhythmias, and thus appropriate screening should be performed.</p><p>See <a href="#kcnt1-epilepsy.Related_Genetic_Counselin">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="kcnt1-epilepsy.Pregnancy_Management"><h3>Pregnancy Management</h3><p>In general, women with epilepsy or a seizure disorder from any cause are at greater risk for mortality during pregnancy than pregnant women without a seizure disorder; use of antiepileptic medication during pregnancy reduces this risk. However, exposure to antiepileptic medication (e.g., valproate, phenobarbital, topiramate) may increase the risk for adverse fetal outcome (depending on the drug used, the dose, and the stage of pregnancy at which medication is taken). Nevertheless, the risk of an adverse outcome to the fetus from antiepileptic medication exposure is often less than that associated with exposure to an untreated maternal seizure disorder. Therefore, use of antiepileptic medication to treat a maternal seizure disorder during pregnancy is typically recommended. Discussion of the risks and benefits of using a given antiepileptic drug during pregnancy should ideally take place prior to conception. Transitioning to a lower-risk medication prior to pregnancy may be possible [<a class="bk_pop" href="#kcnt1-epilepsy.REF.sarma.2016.467">Sarma et al 2016</a>].</p><p>See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for further information on medication use during pregnancy.</p></div><div id="kcnt1-epilepsy.Therapies_Under_Investiga"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="kcnt1-epilepsy.Genetic_Counseling"><h2 id="_kcnt1-epilepsy_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="kcnt1-epilepsy.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>KCNT1</i>-related epilepsy is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="kcnt1-epilepsy.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with <i>KCNT1</i>-related epilepsy have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div><ul><li class="half_rhythm"><div>All individuals diagnosed with <i>KCNT1</i>-related epilepsy of infancy with migrating focal seizures [EIMFS] represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence of EIMFS in the family) and have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or an inherited variant from either a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent with a less severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (e.g., <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> nocturnal frontal lobe epilepsy) or an unaffected parent with somatic and/or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#kcnt1-epilepsy.REF.m_ller.2015.e114">M&#x000f8;ller et al 2015</a>, <a class="bk_pop" href="#kcnt1-epilepsy.REF.ohba.2015.e121">Ohba et al 2015</a>].</div></li><li class="half_rhythm"><div>Some individuals diagnosed with <i>KCNT1</i>-related <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> nocturnal frontal lobe epilepsy (ADNFLE) have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li></ul></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in an unaffected parent. Somatic and germline mosaicism have been reported [<a class="bk_pop" href="#kcnt1-epilepsy.REF.ohba.2015.e121">Ohba et al 2015</a>].</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with <i>KCNT1</i>-related epilepsy may appear to be negative because of failure to recognize the disorder in family members or reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. Therefore, an apparently negative family history cannot be confirmed unless <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li><li class="half_rhythm"><div>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the clinical/genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is known to be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the <i>KCNT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the variant is 50%. Note: Intrafamilial clinical variability and reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in some <i>KCNT1</i> seizure phenotypes has been observed (see <a href="#kcnt1-epilepsy.GenotypePhenotype_Correla">Genotype-Phenotype Correlations</a> and <a href="#kcnt1-epilepsy.Penetrance">Penetrance</a>) [<a class="bk_pop" href="#kcnt1-epilepsy.REF.m_ller.2015.e114">M&#x000f8;ller et al 2015</a>].</div></li><li class="half_rhythm"><div>If the <i>KCNT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is slightly greater than that of the general population because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> or <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> [<a class="bk_pop" href="#kcnt1-epilepsy.REF.m_ller.2015.e114">M&#x000f8;ller et al 2015</a>, <a class="bk_pop" href="#kcnt1-epilepsy.REF.ohba.2015.e121">Ohba et al 2015</a>].</div></li><li class="half_rhythm"><div>If the parents have not been tested for the <i>KCNT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> are still at increased risk for <i>KCNT1</i>-related epilepsy because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent or parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. (Note: Reduced penetrance has not been reported in <i>KCNT1</i>-related EIMFS.)</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>KCNT1</i>-related epilepsy has a 50% chance of inheriting the <i>KCNT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>KCNT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="kcnt1-epilepsy.Related_Genetic_Counselin"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#kcnt1-epilepsy.Evaluation_of_Relatives_a"><u>Evaluation of Relatives at Risk</u></a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="kcnt1-epilepsy.Prenatal_Testing_and_Prei"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>KCNT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="kcnt1-epilepsy.Resources"><h2 id="_kcnt1-epilepsy_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Epilepsy Society (AES)</b></div><div><a href="http://www.aesnet.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aesnet.org</a></div></li><li class="half_rhythm"><div><b>Canadian Epilepsy Alliance</b></div><div>Canada</div><div><b>Phone:</b> 1-866-EPILEPSY (1-866-374-5377)</div><div><a href="http://epilepsymatters.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsymatters.com</a></div></li><li class="half_rhythm"><div><b>Epilepsy Foundation</b></div><div>8301 Professional Place East</div><div>Suite 200</div><div>Landover MD 20785-7223</div><div><b>Phone:</b> 800-332-1000 (toll-free)</div><div><b>Email:</b> ContactUs@efa.org</div><div><a href="https://www.epilepsy.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.com</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="http://www.ninds.nih.gov/disorders/epilepsy/epilepsy.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy Information Page</a></div></li></ul></div><div id="kcnt1-epilepsy.Molecular_Genetics"><h2 id="_kcnt1-epilepsy_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="kcnt1-epilepsy.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>KCNT1-Related Epilepsy: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK525917/table/kcnt1-epilepsy.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kcnt1-epilepsy.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_kcnt1-epilepsy.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_kcnt1-epilepsy.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_kcnt1-epilepsy.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_kcnt1-epilepsy.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_kcnt1-epilepsy.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_kcnt1-epilepsy.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/57582" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KCNT1</i></a></td><td headers="hd_b_kcnt1-epilepsy.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=57582" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9q34<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_kcnt1-epilepsy.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q5JUK3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Potassium channel subfamily T member 1</a></td><td headers="hd_b_kcnt1-epilepsy.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KCNT1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNT1</a></td><td headers="hd_b_kcnt1-epilepsy.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KCNT1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNT1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="kcnt1-epilepsy.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="kcnt1-epilepsy.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for KCNT1-Related Epilepsy (<a href="/omim/608167,614959,615005" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK525917/table/kcnt1-epilepsy.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kcnt1-epilepsy.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608167" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608167</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POTASSIUM CHANNEL, SUBFAMILY T, MEMBER 1; KCNT1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614959" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614959</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615005" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615005</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>KCNT1</i> is located at <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 9q34.3. Although a long and short isoform have been reported in humans, the long isoform (Slack-B) composed of 31 exons is thought to encode the predominantly expressed functional protein and has been more extensively studied. With 1,235 amino acids, it is the largest potassium channel identified thus far. As studies in animals have revealed five splice <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> with different expression patterns and physiologic properties, additional expression studies are necessary in humans to better define <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression.</p><p><b>Pathogenic variants.</b> All pathogenic variants reported to date are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants associated with an epilepsy <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, with the exception of two missense variants identified in individuals with cardiac conduction abnormalities [<a class="bk_pop" href="#kcnt1-epilepsy.REF.juang.2014.6733">Juang et al 2014</a>, <a class="bk_pop" href="#kcnt1-epilepsy.REF.m_ller.2015.e114">M&#x000f8;ller et al 2015</a>]. Whereas most variants in neonates are associated with EIMFS, other phenotypes within the spectrum of infantile-onset epilepsy (e.g., West syndrome or EIEE not consistent with EIMFS) have been reported [<a class="bk_pop" href="#kcnt1-epilepsy.REF.allen.2016.e12">Allen et al 2016</a>, <a class="bk_pop" href="#kcnt1-epilepsy.REF.fukuoka.2017.80">Fukuoka et al 2017</a>].</p><p>The majority of ADNFLE-associated variants have also been observed in individuals with an EIMFS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, consistent with <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> [<a class="bk_pop" href="#kcnt1-epilepsy.REF.heron.2012.1188">Heron et al 2012</a>, <a class="bk_pop" href="#kcnt1-epilepsy.REF.ishii.2013.467">Ishii et al 2013</a>, <a class="bk_pop" href="#kcnt1-epilepsy.REF.steinlein.2014.1">Steinlein 2014</a>, <a class="bk_pop" href="#kcnt1-epilepsy.REF.m_ller.2015.e114">M&#x000f8;ller et al 2015</a>].</p><div id="kcnt1-epilepsy.T.kcnt1_variants_discusse" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>KCNT1</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK525917/table/kcnt1-epilepsy.T.kcnt1_variants_discusse/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kcnt1-epilepsy.T.kcnt1_variants_discusse_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Associated Phenotype</th><th id="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_1" rowspan="20" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">EIMFS</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.769C&#x0003e;G</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His257Asp</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_4" rowspan="37" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_020822.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_020822<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_065873.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_065873<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.785G&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg262Gln</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.808C&#x0003e;G</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln270Glu</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.811G&#x0003e;T</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val271Phe</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.820C&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu274Ile</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1038C&#x0003e;G</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe364Leu</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1225C&#x0003e;T</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro409Ser</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1420C&#x0003e;T</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg474Cys</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1429G&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala477Thr</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1504T&#x0003e;G</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe502Val</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1546A&#x0003e;G</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met516Val</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1885G&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys629Glu</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1887G&#x0003e;C</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys629Asn</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2280C&#x0003e;G</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile760Met</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2687T&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met896Lys</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2771C&#x0003e;T</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro924Leu</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2797C&#x0003e;G</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg933Gly</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2800G&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala934Thr</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2839A&#x0003e;G</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys947Glu</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2849G&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg950Gln</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Temporal lobe epilepsy</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.398G&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg133His</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.3320G&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg1107His</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">ADNFLE</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.862G&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly288Ser</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2386T&#x0003e;C</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr796His</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2688G&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met896Ile</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ADNFLE, EIMFS</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2849G&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg950Gln</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">ADNFLE, EIMFS, multifocal epilepsy</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1018G&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val340Met</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1193G&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg398Gln</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIMFS, multifocal epilepsy</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1283G&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg428Gln</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1799G&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg600Gln</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIMFS, West syndrome, EIEE</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1421G&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg474His</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIMFS, West syndrome</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1955G&#x0003e;T</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly652Val</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">West syndrome, leukodystrophy</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2718G&#x0003e;T</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln906His</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIMFS, ADNFLE, focal epilepsy, cardiac arrhythmia</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2782C&#x0003e;T</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg928Cys</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE, delayed myelination, leukodystrophy</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2794T&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe932Ile</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multifocal epilepsy</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2882G&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg961His</td></tr><tr><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Brugada syndrome</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3317G&#x0003e;A</td><td headers="hd_h_kcnt1-epilepsy.T.kcnt1_variants_discusse_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg1106Gln</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <u>Quick Reference</u> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>KCNT1</i> encodes one of the two known sodium-activated potassium channels, termed the slack ("sequence like A calcium-activated K"; previously known as Slo2.2 and KCa4.1) channel [<a class="bk_pop" href="#kcnt1-epilepsy.REF.joiner.1998.462">Joiner et al1998</a>]. Current nomenclature now refers to KCNT1 as KNa1.1 [<a class="bk_pop" href="#kcnt1-epilepsy.REF.kaczmarek.2017.1">Kaczmarek et al 2017</a>].</p><p>While KNa1.1 possesses six transmembrane domains and a pore <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> between the S5 and S6 transmembrane domains, similar to other voltage-gated potassium channels, its C-terminus is disproportionately large. The C-terminus comprises:</p><ul><li class="half_rhythm"><div>Two regulators of conductance of K+ (RCK) domains that form a ring on the cytoplasmic face of the channel, which, in the presence of sodium, undergoes a conformational shift to expose the electrostatic channel pore [<a class="bk_pop" href="#kcnt1-epilepsy.REF.hite.2015.198">Hite et al 2015</a>];</div></li><li class="half_rhythm"><div>An NAD+ binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> in the C-terminus, which, in the presence of increased NAD+ concentrations, reduces the sodium requirement of the channel [<a class="bk_pop" href="#kcnt1-epilepsy.REF.tamsett.2009.5127">Tamsett et al 2009</a>].</div></li></ul><p>The C-terminus regulates channel opening by interaction with fragile X mental retardation protein (FMRP) [<a class="bk_pop" href="#kcnt1-epilepsy.REF.zhang.2012.15318">Zhang et al 2012</a>].</p><p><i>KCNT1</i> expression is robust throughout the CNS in brain stem nuclei, the cerebellum, and the olfactory bulb and less strongly in the hippocampus and frontal cortex [<a class="bk_pop" href="#kcnt1-epilepsy.REF.bhattacharjee.2002.241">Bhattacharjee et al 2002</a>, <a class="bk_pop" href="#kcnt1-epilepsy.REF.rizzi.2016.2093">Rizzi et al 2016</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Of the variants studied functionally, all confer a <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> channel <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> regardless of the type of associated epilepsy [reviewed in <a class="bk_pop" href="#kcnt1-epilepsy.REF.m_ller.2015.e114">M&#x000f8;ller et al 2015</a>, <a class="bk_pop" href="#kcnt1-epilepsy.REF.lim.2016.217">Lim et al 2016</a>, <a class="bk_pop" href="#kcnt1-epilepsy.REF.mctague.2018.e55">McTague et al 2018</a>], with the exception of p.Phe932Ile, which confers a <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> channel phenotype [<a class="bk_pop" href="#kcnt1-epilepsy.REF.vanderver.2014.112">Vanderver et al 2014</a>].</p><p>Although the majority of variants associated with <i>KCNT1</i>-related EIMFS and <i>KCNT1</i>-related ADNFLE cluster in different regions of the channel (see <a class="figpopup" href="/books/NBK525917/figure/kcnt1-epilepsy.F1/?report=objectonly" target="object" rid-figpopup="figkcnt1epilepsyF1" rid-ob="figobkcnt1epilepsyF1">Figure 1</a>), there is insufficient evidence to predict <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation. Clinical variability is expected.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figkcnt1epilepsyF1" co-legend-rid="figlgndkcnt1epilepsyF1"><a href="/books/NBK525917/figure/kcnt1-epilepsy.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figkcnt1epilepsyF1" rid-ob="figobkcnt1epilepsyF1"><img class="small-thumb" src="/books/NBK525917/bin/kcnt1-epilepsy-Image001.gif" src-large="/books/NBK525917/bin/kcnt1-epilepsy-Image001.jpg" alt="Figure 1. . Pathogenic variants identified in KCNT1-related epilepsy cluster in the S5 transmembrane and the Regulators of Potassium (RCK) domains of the channel protein." /></a><div class="icnblk_cntnt" id="figlgndkcnt1epilepsyF1"><h4 id="kcnt1-epilepsy.F1"><a href="/books/NBK525917/figure/kcnt1-epilepsy.F1/?report=objectonly" target="object" rid-ob="figobkcnt1epilepsyF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Pathogenic variants identified in <i>KCNT1</i>-related epilepsy cluster in the S5 transmembrane and the Regulators of Potassium (RCK) domains of the channel protein. Figure generated from an image drawn using Protter open-source software [Omasits et al 2014] <a href="/books/NBK525917/figure/kcnt1-epilepsy.F1/?report=objectonly" target="object" rid-ob="figobkcnt1epilepsyF1">(more...)</a></p></div></div><p>Several mechanisms of channel dysfunction have been described. Some variants cause a shift in time spent in subconductance states, either secondary to loss of PKC-dependent regulation [<a class="bk_pop" href="#kcnt1-epilepsy.REF.barcia.2012.1255">Barcia et al 2012</a>] or due to enhanced cooperativity of channels leading to increased open channel probability [<a class="bk_pop" href="#kcnt1-epilepsy.REF.kim.2014.1661">Kim et al 2014</a>]. Other pathogenic variants appear hypersensitive to intracellular sodium and thus more likely to be in an open state [<a class="bk_pop" href="#kcnt1-epilepsy.REF.tang.2016.129">Tang et al 2016</a>]. Further research is needed to determine the impact of an enhanced potassium conductance on neuronal firing within regions of the developing brain susceptible to epileptogenesis.</p></div><div id="kcnt1-epilepsy.References"><h2 id="_kcnt1-epilepsy_References_">References</h2><div id="kcnt1-epilepsy.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.abdelnour.2018.1">Abdelnour E, Gallentine W, McDonald M, Sachdev M, Jiang YH, Mikati MA. Does age affect response to quinidine in patients with KCNT1 mutations? Report of three new cases and review of the literature. <span><span class="ref-journal">Seizure. </span>2018;<span class="ref-vol">55</span>:1–3.</span> [<a href="/pubmed/29291456" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29291456</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.allen.2016.e12">Allen NM, Conroy J, Shahwan A, Lynch B, Correa RG, Pena SD, McCreary D, Magalh&#x000e3;es TR, Ennis S, Lynch SA, King MD. Unexplained early onset epileptic encephalopathy: exome screening and phenotype expansion. <span><span class="ref-journal">Epilepsia. </span>2016;<span class="ref-vol">57</span>:e12–7.</span> [<a href="/pubmed/26648591" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26648591</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.barcia.2012.1255">Barcia G, Fleming MR, Deligniere A, Gazula VR, Brown MR, Langouet M, Chen H, Kronengold J, Abhyankar A, Cilio R, Nitschke P, Kaminska A, Boddaert N, Casanova JL, Desguerre I, Munnich A, Dulac O, Kaczmarek LK, Colleaux L, Nabbout R. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:1255–9.</span> [<a href="/pmc/articles/PMC3687547/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3687547</span></a>] [<a href="/pubmed/23086397" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23086397</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.bearden.2014.457">Bearden D, Strong A, Ehnot J, DiGiovine M, Dlugos D, Goldberg EM. Targeted treatment of migrating partial seizures of infancy with quinidine. <span><span class="ref-journal">Ann Neurol. </span>2014;<span class="ref-vol">76</span>:457–61.</span> [<a href="/pubmed/25042079" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25042079</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.berg.2010.676">Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Mosh&#x000e9; SL, Nordli D, Plouin P, Scheffer IE. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. <span><span class="ref-journal">Epilepsia. </span>2010;<span class="ref-vol">51</span>:676–85.</span> [<a href="/pubmed/20196795" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20196795</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.bhattacharjee.2002.241">Bhattacharjee A, Gan L, Kaczmarek LK. Localization of the Slack potassium channel in the rat central nervous system. <span><span class="ref-journal">J Comp Neurol. </span>2002;<span class="ref-vol">454</span>:241–54.</span> [<a href="/pubmed/12442315" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12442315</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.caraballo.2008.497">Caraballo RH, Fontana E, Darra F, Cassar L, Negrini F, Fiorini E, Arroyo H, Ferraro S, Fejerman N, Dalla Bernardina B. Migrating focal seizures in infancy: analysis of the electroclinical patterns in 17 patients. <span><span class="ref-journal">J Child Neurol. </span>2008;<span class="ref-vol">23</span>:497–506.</span> [<a href="/pubmed/18230844" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18230844</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.cilio.2009.66">Cilio MR, Bianchi R, Balestri M, Onofri A, Giovannini S, Di Capua M, Vigevano F. Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy. <span><span class="ref-journal">Epilepsy Res. </span>2009;<span class="ref-vol">86</span>:66–71.</span> [<a href="/pubmed/19520548" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19520548</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.coppola.1995.1017">Coppola G, Plouin P, Chiron C, Robain O, Dulac O. Migrating partial seizures in infancy: a malignant disorder with developmental arrest. <span><span class="ref-journal">Epilepsia. </span>1995;<span class="ref-vol">36</span>:1017–24.</span> [<a href="/pubmed/7555952" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7555952</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.fukuoka.2017.80">Fukuoka M, Kuki I, Kawawaki H, Okazaki S, Kim K, Hattori Y, Tsuji H, Nukui M, Inoue T, Yoshida Y, Uda T, Kimura S, Mogami Y, Suzuki Y, Okamoto N, Saitsu H, Matsumoto N. Quinidine therapy for West syndrome with KCNTI mutation: a case report. <span><span class="ref-journal">Brain Dev. </span>2017;<span class="ref-vol">39</span>:80–3.</span> [<a href="/pubmed/27578169" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27578169</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.hansen.2017.181">Hansen N, Widman G, Hattingen E, Elger CE, Kunz WS. Mesial temporal lobe epilepsy associated with KCNT1 mutation. <span><span class="ref-journal">Seizure. </span>2017;<span class="ref-vol">45</span>:181–3.</span> [<a href="/pubmed/28081520" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28081520</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.heron.2012.1188">Heron SE, Smith KR, Bahlo M, Nobili L, Kahana E, Licchetta L, Oliver KL, Mazarib A, Afawi Z, Korczyn A, Plazzi G, Petrou S, Berkovic SF, Scheffer IE, Dibbens LM. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:1188–90.</span> [<a href="/pubmed/23086396" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23086396</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.hite.2015.198">Hite RK, Yuan P, Li Z, Hsuing Y, Walz T, MacKinnon R. Cryo-electron microscopy structure of the Slo2.2 Na(+)-activated K(+) channel. <span><span class="ref-journal">Nature. </span>2015;<span class="ref-vol">527</span>:198–203.</span> [<a href="/pmc/articles/PMC4886347/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4886347</span></a>] [<a href="/pubmed/26436452" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26436452</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.hmaimess.2006.55">Hmaimess G, Kadhim H, Nassogne MC, Bonnier C, van Rijckevorsel K. Levetiracetam in a neonate with malignant migrating partial seizures. <span><span class="ref-journal">Pediatr Neurol. </span>2006;<span class="ref-vol">34</span>:55–9.</span> [<a href="/pubmed/16376281" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16376281</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.ishii.2013.467">Ishii A, Shioda M, Okumura A, Kidokoro H, Sakauchi M, Shimada S, Shimizu T, Osawa M, Hirose S, Yamamoto T. A recurrent KCNT1 mutation in two sporadic cases with malignant migrating partial seizures in infancy. <span><span class="ref-journal">Gene. </span>2013;<span class="ref-vol">531</span>:467–71.</span> [<a href="/pubmed/24029078" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24029078</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.joiner.1998.462">Joiner WJ, Tang MD, Wang LY, Dworetzky SI, Boissard CG, Gan L, Gribkoff VK, Kaczmarek LK. Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits. <span><span class="ref-journal">Nat Neurosci. </span>1998;<span class="ref-vol">1</span>:462–9.</span> [<a href="/pubmed/10196543" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10196543</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.juang.2014.6733">Juang JM, Lu TP, Lai LC, Ho CC, Liu YB, Tsai CT, Lin LY, Yu CC, Chen WJ, Chiang FT, Yeh SF, Lai LP, Chuang EY, Lin JL. Disease-targeted sequencing of ion channel genes identifies de novo mutations in patients with non-familial Brugada syndrome. <span><span class="ref-journal">Sci Rep. </span>2014;<span class="ref-vol">4</span>:6733.</span> [<a href="/pmc/articles/PMC4206841/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4206841</span></a>] [<a href="/pubmed/25339316" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25339316</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.kaczmarek.2017.1">Kaczmarek LK, Aldrich RW, Chandy KG, Grissmer S, Wei AD, Wulff H. International Union of Basic and Clinical Pharmacology. C. Nomenclature and properties of calcium-activated and sodium-activated potassium channels. <span><span class="ref-journal">Pharmacol Rev. </span>2017;<span class="ref-vol">69</span>:1–11.</span> [<a href="/pubmed/28267675" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28267675</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.kawasaki.2017.270">Kawasaki Y, Kuki I, Ehara E, Murakami Y, Okazaki S, Kawawaki H, Hara M, Watanabe Y, Kishimoto S, Suda K, Saitsu H, Matsumoto N. Three cases of KCNT1 mutations: malignant migrating partial seizures in infancy with massive systemic to pulmonary collateral arteries. <span><span class="ref-journal">J Pediatr. </span>2017;<span class="ref-vol">191</span>:270–4.</span> [<a href="/pubmed/28987752" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28987752</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.kim.2014.1661">Kim GE, Kronengold J, Barcia G, Quraishi IH, Martin HC, Blair E, Taylor JC, Dulac O, Colleaux L, Nabbout R, Kaczmarek LK. Human slack potassium channel mutations increase positive cooperativity between individual channels. <span><span class="ref-journal">Cell Rep. </span>2014;<span class="ref-vol">9</span>:1661–72.</span> [<a href="/pmc/articles/PMC4294418/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4294418</span></a>] [<a href="/pubmed/25482562" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25482562</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.lim.2016.217">Lim CX, Ricos MG, Dibbens LM, Heron SE. KCNT1 mutations in seizure disorders: the phenotypic spectrum and functional effects. <span><span class="ref-journal">J Med Genet. </span>2016;<span class="ref-vol">53</span>:217–25.</span> [<a href="/pubmed/26740507" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26740507</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.liu.2015.1795">Liu L, Collier AC, Link JM, Domino KB, Mankoff DA, Eary JF, Spiekerman CF, Hsiao P, Deo AK, Unadkat JD. Modulation of P-glycoprotein at the human blood-brain barrier by quinidine or rifampin treatment: a positron emission tomography imaging study. <span><span class="ref-journal">Drug Metab Dispos. </span>2015;<span class="ref-vol">43</span>:1795–804.</span> [<a href="/pmc/articles/PMC4613948/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4613948</span></a>] [<a href="/pubmed/26354948" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26354948</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.mctague.2013.1578">McTague A, Appleton R, Avula S, Cross JH, King MD, Jacques TS, Bhate S, Cronin A, Curran A, Desurkar A, Farrell MA, Hughes E, Jefferson R, Lascelles K, Livingston J, Meyer E, McLellan A, Poduri A, Scheffer IE, Spinty S, Kurian MA, Kneen R. Migrating partial seizures of infancy: expansion of the electroclinical, radiological and pathological disease spectrum. <span><span class="ref-journal">Brain. </span>2013;<span class="ref-vol">136</span>:1578–91.</span> [<a href="/pmc/articles/PMC3634200/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3634200</span></a>] [<a href="/pubmed/23599387" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23599387</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.mctague.2018.e55">McTague A, Nair U, Malhotra S, Meyer E, Trump N, Gazina EV, Papandreou A, Ngoh A, Ackermann S, Ambegaonkar G, Appleton R, Desurkar A, Eltze C, Kneen R, Kumar AV, Lascelles K, Montgomery T, Ramesh V, Samanta R, Scott RH, Tan J, Whitehouse W, Poduri A, Scheffer IE, Chong WKK, Cross JH, Topf M, Petrou S, Kurian MA. Clinical and molecular characterization of KCNT1-related severe early-onset epilepsy. <span><span class="ref-journal">Neurology. </span>2018;<span class="ref-vol">90</span>:e55–e66.</span> [<a href="/pmc/articles/PMC5754647/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5754647</span></a>] [<a href="/pubmed/29196579" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29196579</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.m_ller.2015.e114">M&#x000f8;ller RS, Heron SE, Larsen LH, Lim CX, Ricos MG, Bayly MA, van Kempen MJ, Klinkenberg S, Andrews I, Kelley K, Ronen GM, Callen D, McMahon JM, Yendle SC, Carvill GL, Mefford HC, Nabbout R, Poduri A, Striano P, Baglietto MG, Zara F, Smith NJ, Pridmore C, Gardella E, Nikanorova M, Dahl HA, Gellert P, Scheffer IE, Gunning B, Kragh-Olsen B, Dibbens LM. Mutations in KCNT1 cause a spectrum of focal epilepsies. <span><span class="ref-journal">Epilepsia. </span>2015;<span class="ref-vol">56</span>:e114–20.</span> [<a href="/pmc/articles/PMC5915334/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5915334</span></a>] [<a href="/pubmed/26122718" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26122718</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.mullen.2018.e67">Mullen SA, Carney PW, Roten A, Ching M, Lightfoot PA, Churilov L, Nair U, Li M, Berkovic SF, Petrou S, Scheffer IE. Precision therapy for epilepsy due to KCNT1 mutations: a randomized trial of oral quinidine. <span><span class="ref-journal">Neurology. </span>2018;<span class="ref-vol">90</span>:e67–e72.</span> [<a href="/pubmed/29196578" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29196578</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.ohba.2015.e121">Ohba C, Kato M, Takahashi N, Osaka H, Shiihara T, Tohyama J, Nabatame S, Azuma J, Fujii Y, Hara M, Tsurusawa R, Inoue T, Ogata R, Watanabe Y, Togashi N, Kodera H, Nakashima M, Tsurusaki Y, Miyake N, Tanaka F, Saitsu H, Matsumoto N. De novo KCNT1 mutations in early-onset epileptic encephalopathy. <span><span class="ref-journal">Epilepsia. </span>2015;<span class="ref-vol">56</span>:e121–8.</span> [<a href="/pubmed/26140313" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26140313</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.omasits.2014.884">Omasits U, Ahrens CH, M&#x000fc;ller S, Wollscheid B. Protter: interactive protein feature visualization and integration with experimental proteomic data. <span><span class="ref-journal">Bioinformatics. </span>2014;<span class="ref-vol">30</span>:884–6.</span> [<a href="/pubmed/24162465" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24162465</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.rizzi.2016.2093">Rizzi S, Knaus HG, Schwarzer C. Differential distribution of the sodium-activated potassium channels slick and slack in mouse brain. <span><span class="ref-journal">J Comp Neurol. </span>2016;<span class="ref-vol">524</span>:2093–116.</span> [<a href="/pmc/articles/PMC4982087/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4982087</span></a>] [<a href="/pubmed/26587966" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26587966</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.sarma.2016.467">Sarma AK, Khandker N, Kurczewski L, Brophy GM. Medical management of epileptic seizures: challenges and solutions. <span><span class="ref-journal">Neuropsychiatr Dis Treat. </span>2016;<span class="ref-vol">12</span>:467–85.</span> [<a href="/pmc/articles/PMC4771397/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4771397</span></a>] [<a href="/pubmed/26966367" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26966367</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.steinlein.2014.1">Steinlein OK. Genetic heterogeneity in familial nocturnal frontal lobe epilepsy. <span><span class="ref-journal">Prog Brain Res. </span>2014;<span class="ref-vol">213</span>:1–15.</span> [<a href="/pubmed/25194481" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25194481</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.tamsett.2009.5127">Tamsett TJ, Picchione KE, Bhattacharjee A. NAD+ activates KNa channels in dorsal root ganglion neurons. <span><span class="ref-journal">J Neurosci. </span>2009;<span class="ref-vol">29</span>:5127–34.</span> [<a href="/pmc/articles/PMC6665483/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6665483</span></a>] [<a href="/pubmed/19386908" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19386908</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.tang.2016.129">Tang QY, Zhang FF, Xu J, Wang R, Chen J, Logothetis DE, Zhang Z. Epilepsy-related slack channel mutants lead to channel over-activity by two different mechanisms. <span><span class="ref-journal">Cell Rep. </span>2016;<span class="ref-vol">14</span>:129–39.</span> [<a href="/pmc/articles/PMC4706775/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4706775</span></a>] [<a href="/pubmed/26725113" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26725113</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.vanderver.2014.112">Vanderver A, Simons C, Schmidt JL, Pearl PL, Bloom M, Lavenstein B, Miller D, Grimmond SM, Taft RJ. Identification of a novel de novo p.Phe932Ile KCNT1 mutation in a patient with leukoencephalopathy and severe epilepsy. <span><span class="ref-journal">Pediatr Neurol. </span>2014;<span class="ref-vol">50</span>:112–4.</span> [<a href="/pmc/articles/PMC4303471/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4303471</span></a>] [<a href="/pubmed/24120652" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24120652</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.zamponi.2008.291">Zamponi N, Rychlicki F, Corpaci L, Cesaroni E, Trignani R. Vagus nerve stimulation (VNS) is effective in treating catastrophic 1 epilepsy in very young children. <span><span class="ref-journal">Neurosurg Rev. </span>2008;<span class="ref-vol">31</span>:291–7.</span> [<a href="/pubmed/18446391" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18446391</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnt1-epilepsy.REF.zhang.2012.15318">Zhang Y, Brown MR, Hyland C, Chen Y, Kronengold J, Fleming MR, Kohn AB, Moroz LL, Kaczmarek LK. Regulation of neuronal excitability by interaction of fragile X mental retardation protein with slack potassium channels. <span><span class="ref-journal">J Neurosci. </span>2012;<span class="ref-vol">32</span>:15318–27.</span> [<a href="/pmc/articles/PMC3518385/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3518385</span></a>] [<a href="/pubmed/23115170" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23115170</span></a>]</div></li></ul></div></div><div id="kcnt1-epilepsy.Chapter_Notes"><h2 id="_kcnt1-epilepsy_Chapter_Notes_">Chapter Notes</h2><div id="kcnt1-epilepsy.Author_Notes"><h3>Author Notes</h3><p>The <i>KCNT1</i> Registry includes individuals with epilepsy and known or suspected pathogenic variants in <i>KCNT1</i>. The registry is an ongoing natural history study of <i>KCNT1</i>-related epilepsy. Individuals interested in participating in the <i>KCNT1</i> Registry should contact Dr David Bearden at david_bearden@urmc.rochester.edu.</p></div><div id="kcnt1-epilepsy.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>20 September 2018 (tg) Review posted live</div></li><li class="half_rhythm"><div>28 February 2018 (jlr) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK525917</span><span class="label">PMID: <a href="/pubmed/30234941" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">30234941</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/kcnq3-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/kmt2b-dystonia/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK525917&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK525917/?report=reader">PubReader</a></li><li><a href="/books/NBK525917/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK525917" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK525917" style="display:none" title="Cite this Page"><div class="bk_tt">Gertler T, Bearden D, Bhattacharjee A, et al. KCNT1-Related Epilepsy. 2018 Sep 20. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK525917/pdf/Bookshelf_NBK525917.pdf">PDF version of this page</a> (623K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#kcnt1-epilepsy.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#kcnt1-epilepsy.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#kcnt1-epilepsy.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#kcnt1-epilepsy.Genetically_Related_Allel" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#kcnt1-epilepsy.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#kcnt1-epilepsy.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#kcnt1-epilepsy.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#kcnt1-epilepsy.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#kcnt1-epilepsy.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#kcnt1-epilepsy.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#kcnt1-epilepsy.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=57582[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KCNT1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4614428" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4614428" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4614428" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4614428" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301348" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autosomal Dominant Nocturnal Frontal Lobe Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autosomal Dominant Nocturnal Frontal Lobe Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kurahashi H, Hirose S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301494" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SCN1A</i> Seizure Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SCN1A</i> Seizure Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Miller IO, Sotero de Menezes MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301294" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brashear A, Sweadner KJ, Cook JF, Swoboda KJ, Ozelius L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301603" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wang D, Pascual JM, De Vivo D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30763027" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SLC12A5</i>-Related Epilepsy of Infancy with Migrating Focal Seizures</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SLC12A5</i>-Related Epilepsy of Infancy with Migrating Focal Seizures<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">McTague A, Kurian MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=30234941" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=30234941" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0417e0dde08911692e599a">KCNT1-Related Epilepsy - GeneReviews®</a><div class="ralinkpop offscreen_noflow">KCNT1-Related Epilepsy - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:16:00-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8C22F0E04173210000000000450016&amp;ncbi_session=CE8C22F0E0417E01_0069SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK525917%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK525917&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK525917/&amp;ncbi_pagename=KCNT1-Related Epilepsy - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C22F0E0417E01_0069SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>